论文信息 - Development of a chiral HPLC method to evaluate in vivo enantiomeric inversion of an unstable, polar radiosensitizer in plasma. - 字舞流文

Development of a chiral HPLC method to evaluate in vivo enantiomeric inversion of an unstable, polar radiosensitizer in plasma.

K. Hoffman | C. Lathia | D. T. Rossi | J. Kagel | B. Leja

[1] K. Hoffman,et al. An HPLC assay utilizing solid-phase extraction for CI-1010, an alkylating radiosensitizer, in rat plasma. , 1997, Journal of pharmaceutical and biomedical analysis.

[2] C. Lathia,et al. Management of nonmatrix interfering peaks in a chiral high-performance liquid chromatographic assay produced by solid-phase extraction of rat plasma. , 1997, Journal of chromatography. A.

[3] S. Mehta,et al. Preformulation studies to aid in the development of an injectable formulation of PD 144872, a radiosensitizing anticancer agent , 1994 .

[4] V. Stella,et al. A liquid chromatographic method for the determination of the enantiomeric purity of the anticancer drug, 9-amino-20(S)-camptothecin. , 1993, Journal of pharmaceutical and biomedical analysis.

[5] R. Lewis,et al. Quantitation of a novel antiemetic (ADR-851) in plasma and urine by reversed-phase high-performance liquid chromatography with fluorescence detection. , 1991, Journal of chromatography.

[6] A. Krstulović. Chiral separations by HPLC , 1989 .

[7] John W. Dolan,et al. Introduction to modern liquid chromatography , 1974 .

[8] Herbert O. House,et al. Modern Synthetic Reactions , 1972 .